annual SGA:
$14.08B+$2.40B(+20.55%)Summary
- As of today (May 19, 2025), GSK annual SGA is $14.08 billion, with the most recent change of +$2.40 billion (+20.55%) on December 31, 2024.
- During the last 3 years, GSK annual SGA has risen by +$4.35 billion (+44.73%).
- GSK annual SGA is now -28.36% below its all-time high of $19.65 billion, reached on December 31, 2010.
Performance
GSK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$2.61B-$803.07M(-23.55%)Summary
- As of today (May 19, 2025), GSK quarterly SGA is $2.61 billion, with the most recent change of -$803.07 million (-23.55%) on March 31, 2025.
- Over the past year, GSK quarterly SGA has dropped by -$40.71 million (-1.54%).
- GSK quarterly SGA is now -60.29% below its all-time high of $6.56 billion, reached on December 31, 2010.
Performance
GSK quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$42.34B+$728.91M(+1.75%)Summary
- As of today (May 19, 2025), GSK TTM SGA is $42.34 billion, with the most recent change of +$728.91 million (+1.75%) on March 31, 2025.
- Over the past year, GSK TTM SGA has increased by +$30.62 billion (+261.29%).
- GSK TTM SGA is now -26.30% below its all-time high of $57.45 billion.
Performance
GSK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GSK Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.6% | -1.5% | +261.3% |
| 3 y3 years | +44.7% | +7.2% | +320.8% |
| 5 y5 years | -3.3% | -30.3% | +181.1% |
GSK Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | -47.3% | +7.7% | -7.4% | +81.9% |
| 5 y | 5-year | -3.3% | +47.5% | -47.3% | +330.5% | -7.4% | +153.3% |
| alltime | all time | -28.4% | >+9999.0% | -60.3% | +330.5% | -26.3% | +230.5% |
GSK Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.61B(-23.6%) | $14.07B(-0.3%) |
| Dec 2024 | $14.08B(+20.5%) | $3.41B(-31.0%) | $14.11B(+0.6%) |
| Sep 2024 | - | $4.94B(+59.0%) | $14.03B(+17.0%) |
| Jun 2024 | - | $3.11B(+17.5%) | $11.99B(+2.3%) |
| Mar 2024 | - | $2.65B(-20.4%) | $11.72B(+0.4%) |
| Dec 2023 | $11.68B(+12.6%) | $3.33B(+14.4%) | $11.68B(+4.1%) |
| Sep 2023 | - | $2.91B(+2.4%) | $11.22B(+4.5%) |
| Jun 2023 | - | $2.84B(+9.0%) | $10.73B(+2.3%) |
| Mar 2023 | - | $2.60B(-9.1%) | $10.49B(+1.7%) |
| Dec 2022 | $10.37B(+6.6%) | $2.87B(+18.5%) | $10.31B(-0.9%) |
| Sep 2022 | - | $2.42B(-6.8%) | $10.40B(+1.0%) |
| Jun 2022 | - | $2.60B(+6.8%) | $10.30B(+2.3%) |
| Mar 2022 | - | $2.43B(-17.8%) | $10.06B(-8.3%) |
| Dec 2021 | $9.73B(+1.9%) | $2.96B(+27.7%) | $10.98B(+59.3%) |
| Sep 2021 | - | $2.31B(-1.9%) | $6.89B(-14.1%) |
| Jun 2021 | - | $2.36B(-29.4%) | $8.02B(-11.1%) |
| Mar 2021 | - | $3.35B(-395.9%) | $9.02B(-4.2%) |
| Dec 2020 | $9.55B(-34.4%) | -$1.13B(-132.8%) | $9.42B(-37.2%) |
| Sep 2020 | - | $3.45B(+2.7%) | $14.98B(-0.8%) |
| Jun 2020 | - | $3.36B(-10.1%) | $15.10B(+0.2%) |
| Mar 2020 | - | $3.74B(-15.7%) | $15.06B(+3.5%) |
| Dec 2019 | $14.56B(+10.1%) | $4.44B(+24.5%) | $14.55B(+7.9%) |
| Sep 2019 | - | $3.56B(+7.1%) | $13.49B(+2.1%) |
| Jun 2019 | - | $3.33B(+3.2%) | $13.22B(-0.1%) |
| Mar 2019 | - | $3.23B(-4.3%) | $13.24B(+0.1%) |
| Dec 2018 | $13.23B(+5.9%) | $3.37B(+2.4%) | $13.22B(+0.1%) |
| Sep 2018 | - | $3.29B(-1.7%) | $13.22B(+2.1%) |
| Jun 2018 | - | $3.35B(+4.2%) | $12.95B(+2.4%) |
| Mar 2018 | - | $3.21B(-4.5%) | $12.64B(+1.4%) |
| Dec 2017 | $12.49B(-1.6%) | $3.36B(+11.3%) | $12.46B(-0.0%) |
| Sep 2017 | - | $3.02B(-0.7%) | $12.47B(+0.1%) |
| Jun 2017 | - | $3.04B(+0.1%) | $12.46B(-0.7%) |
| Mar 2017 | - | $3.04B(-9.8%) | $12.54B(-0.8%) |
| Dec 2016 | $12.69B(-10.1%) | $3.37B(+11.9%) | $12.63B(-3.2%) |
| Sep 2016 | - | $3.01B(-3.6%) | $13.06B(-0.3%) |
| Jun 2016 | - | $3.12B(-0.3%) | $13.09B(-5.5%) |
| Mar 2016 | - | $3.13B(-17.3%) | $13.86B(-1.7%) |
| Dec 2015 | $14.11B(+3.8%) | $3.79B(+24.2%) | $14.10B(+2.2%) |
| Sep 2015 | - | $3.05B(-21.6%) | $13.81B(-2.2%) |
| Jun 2015 | - | $3.89B(+15.4%) | $14.12B(+3.2%) |
| Mar 2015 | - | $3.37B(-3.4%) | $13.68B(+0.8%) |
| Dec 2014 | $13.59B(+2.4%) | $3.49B(+3.9%) | $13.57B(-0.5%) |
| Sep 2014 | - | $3.36B(-2.8%) | $13.64B(+2.1%) |
| Jun 2014 | - | $3.46B(+6.0%) | $13.36B(+0.4%) |
| Mar 2014 | - | $3.26B(-8.4%) | $13.30B(+0.2%) |
| Dec 2013 | $13.27B(-4.7%) | $3.56B(+15.8%) | $13.27B(+0.1%) |
| Sep 2013 | - | $3.08B(-9.6%) | $13.26B(-3.3%) |
| Jun 2013 | - | $3.40B(+5.3%) | $13.71B(-0.6%) |
| Mar 2013 | - | $3.23B(-9.0%) | $13.79B(-1.0%) |
| Dec 2012 | $13.93B(+2.1%) | $3.55B(+0.5%) | $13.93B(+1.0%) |
| Sep 2012 | - | $3.53B(+1.4%) | $13.79B(+2.1%) |
| Jun 2012 | - | $3.48B(+3.5%) | $13.50B(-1.3%) |
| Mar 2012 | - | $3.36B(-1.4%) | $13.68B(+0.2%) |
| Dec 2011 | $13.65B(-30.6%) | $3.41B(+5.3%) | $13.65B(-18.8%) |
| Sep 2011 | - | $3.24B(-11.5%) | $16.80B(+0.5%) |
| Jun 2011 | - | $3.66B(+9.9%) | $16.72B(-13.5%) |
| Mar 2011 | - | $3.33B(-49.2%) | $19.32B(-1.7%) |
| Dec 2010 | $19.65B | $6.56B(+107.7%) | $19.65B(+9.7%) |
| Sep 2010 | - | $3.16B(-49.5%) | $17.91B(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2010 | - | $6.26B(+70.9%) | $18.27B(+17.4%) |
| Mar 2010 | - | $3.66B(-24.1%) | $15.57B(+3.3%) |
| Dec 2009 | $15.02B(+6.1%) | $4.83B(+37.1%) | $15.07B(+8.9%) |
| Sep 2009 | - | $3.52B(-1.1%) | $13.84B(+0.6%) |
| Jun 2009 | - | $3.56B(+12.6%) | $13.75B(+0.1%) |
| Mar 2009 | - | $3.16B(-12.0%) | $13.73B(-2.1%) |
| Dec 2008 | $14.16B(+3.7%) | $3.59B(+4.5%) | $14.02B(+1.0%) |
| Sep 2008 | - | $3.44B(-2.9%) | $13.89B(+1.2%) |
| Jun 2008 | - | $3.54B(+2.6%) | $13.72B(-0.8%) |
| Mar 2008 | - | $3.45B(-0.3%) | $13.83B(+1.3%) |
| Dec 2007 | $13.66B(+2.1%) | $3.46B(+5.9%) | $13.65B(-1.8%) |
| Sep 2007 | - | $3.27B(-10.6%) | $13.90B(+1.7%) |
| Jun 2007 | - | $3.66B(+11.8%) | $13.66B(+1.6%) |
| Mar 2007 | - | $3.27B(-11.7%) | $13.45B(+0.6%) |
| Dec 2006 | $13.38B(+1.4%) | $3.70B(+22.3%) | $13.37B(+1.1%) |
| Sep 2006 | - | $3.03B(-12.1%) | $13.23B(-2.5%) |
| Jun 2006 | - | $3.45B(+7.9%) | $13.57B(+2.5%) |
| Mar 2006 | - | $3.19B(-10.4%) | $13.24B(+0.6%) |
| Dec 2005 | $13.19B(-0.0%) | $3.56B(+5.7%) | $13.16B(-1.9%) |
| Sep 2005 | - | $3.37B(+8.2%) | $13.41B(+2.8%) |
| Jun 2005 | - | $3.12B(+0.1%) | $13.04B(-0.8%) |
| Mar 2005 | - | $3.11B(-18.4%) | $13.15B(-0.4%) |
| Dec 2004 | $13.19B(+6.5%) | $3.81B(+27.1%) | $13.20B(+3.3%) |
| Sep 2004 | - | $3.00B(-6.9%) | $12.79B(-1.1%) |
| Jun 2004 | - | $3.22B(+1.7%) | $12.93B(+1.9%) |
| Mar 2004 | - | $3.17B(-6.7%) | $12.68B(+2.3%) |
| Dec 2003 | $12.38B(+7322.3%) | $3.40B(+8.1%) | $12.39B(+37.8%) |
| Sep 2003 | - | $3.14B(+5.7%) | $8.99B(+2.0%) |
| Jun 2003 | - | $2.97B(+3.3%) | $8.82B(-0.4%) |
| Mar 2003 | - | $2.88B(-2.9%) | $8.85B(-14.6%) |
| Dec 2002 | $166.82M(-98.4%) | - | - |
| Sep 2002 | - | $2.96B(-1.5%) | $10.37B(-0.9%) |
| Jun 2002 | - | $3.01B(+11.8%) | $10.46B(+0.7%) |
| Mar 2002 | - | $2.69B(+58.1%) | $10.39B(-3.4%) |
| Dec 2001 | $10.76B(+6124.7%) | $1.70B(-44.4%) | $10.75B(+18.8%) |
| Sep 2001 | - | $3.06B(+4.3%) | $9.05B(+5.9%) |
| Jun 2001 | - | $2.93B(-4.0%) | $8.55B(+2.0%) |
| Mar 2001 | - | $3.06B(+19.5%) | $8.38B(+7.0%) |
| Dec 2000 | $172.79M(+78.0%) | - | - |
| Sep 2000 | - | $2.56B(-7.7%) | $7.83B(+48.5%) |
| Jun 2000 | - | $2.77B(+10.6%) | $5.27B(+44.1%) |
| Mar 2000 | - | $2.50B(+117.0%) | $3.66B(+217.0%) |
| Dec 1999 | $97.09M(+1.0%) | - | - |
| Jun 1999 | - | $1.15B(+5.2%) | $1.15B(+5.2%) |
| Dec 1998 | $96.13M(+8.7%) | - | - |
| Jun 1998 | - | $1.10B | $1.10B |
| Dec 1997 | $88.46M(-20.2%) | - | - |
| Dec 1996 | $110.89M(-26.0%) | - | - |
| Dec 1995 | $149.95M(-97.5%) | - | - |
| Jun 1995 | $5.98B(+7896.5%) | - | - |
| Jun 1994 | $74.83M(+0.1%) | - | - |
| Jun 1993 | $74.77M(+1.2%) | - | - |
| Jun 1992 | $73.88M(+7.6%) | - | - |
| Jun 1991 | $68.65M(+8.2%) | - | - |
| Jun 1990 | $63.47M(+42.2%) | - | - |
| Jun 1989 | $44.62M(+154.5%) | - | - |
| Jun 1988 | $17.54M(+91.6%) | - | - |
| Jun 1987 | $9.15M(+27.1%) | - | - |
| Jun 1986 | $7.20M | - | - |
FAQ
- What is GSK annual SGA?
- What is the all time high annual SGA for GSK?
- What is GSK annual SGA year-on-year change?
- What is GSK quarterly SGA?
- What is the all time high quarterly SGA for GSK?
- What is GSK quarterly SGA year-on-year change?
- What is GSK TTM SGA?
- What is the all time high TTM SGA for GSK?
- What is GSK TTM SGA year-on-year change?
What is GSK annual SGA?
The current annual SGA of GSK is $14.08B
What is the all time high annual SGA for GSK?
GSK all-time high annual SGA is $19.65B
What is GSK annual SGA year-on-year change?
Over the past year, GSK annual SGA has changed by +$2.40B (+20.55%)
What is GSK quarterly SGA?
The current quarterly SGA of GSK is $2.61B
What is the all time high quarterly SGA for GSK?
GSK all-time high quarterly SGA is $6.56B
What is GSK quarterly SGA year-on-year change?
Over the past year, GSK quarterly SGA has changed by -$40.71M (-1.54%)
What is GSK TTM SGA?
The current TTM SGA of GSK is $42.34B
What is the all time high TTM SGA for GSK?
GSK all-time high TTM SGA is $57.45B
What is GSK TTM SGA year-on-year change?
Over the past year, GSK TTM SGA has changed by +$30.62B (+261.29%)